Tizanidine
Product Images NDC 54868-4939

5 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 54868-4939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of 2 mg Package Label (2mg Package Label)

Image Of 2 mg Package Label (2mg Package Label)
Tizanidine 2 mg tablets packaging label from Physicians Total Care, Inc. The label indicates 30 tablets per bottle and includes the active ingredient Tizanidine Hydrochloride. It also features cautionary information about federal dispensing restrictions and contains barcode and lot number details.*
FDA Label Image

Image Of 4 mg Package Label (4mg Package Label)

Image Of 4 mg Package Label (4mg Package Label)
Tizanidine 4 mg tablets packaging label from Physicians Total Care, Inc. The label includes the active ingredient name Tizanidine Hydrochloride and prominently displays dosage strength. It contains cautions about prescription dispensing, lot number, and expiration date details, as well as storage instructions and barcode information.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure of Tizanidine hydrochloride, illustrating its fused bicyclic ring system, including a chlorinated aromatic ring and an imidazoline moiety.*
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
A line graph depicting improvement in Ashworth Score over hours post-dose for Tizanidine. Three lines represent placebo, 8 mg tizanidine, and 16 mg tizanidine doses, showing highest improvement around 2 hours post-dose for 16 mg. Error bars indicate variability around data points.*
FDA Label Image

Image Of Figure 2 (Figure 2)

Image Of Figure 2 (Figure 2)
A line graph comparing improvement in Ashworth Score between Tizanidine (mean dose 28.8 mg) and placebo groups at three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The graph shows error bars for each data point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.